Pentoxifylline immunomodulation in the treatment of experimental chronic pulmonary paracoccidioidomycosis.
Damaris Elena LoperaTonny Williams NaranjoJosé Miguel HidalgoLaura EcheverriJairo Hernando PatiñoÁngela Restrepo MorenoHenrique Leonel LenziLuz Elena CanoPublished in: Fibrogenesis & tissue repair (2015)
This study showed that PTX therapy administered at an "early" stage of granulomatous inflammation controlled the progress of the PCM by diminishing the pulmonary inflammation and the fungal burden and avoiding the appearance of collagen deposits in the pulmonary lesions.